{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:46:23Z","timestamp":1769503583362,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10014-017-0302-z","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T08:33:30Z","timestamp":1510648410000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations"],"prefix":"10.1007","volume":"35","author":[{"given":"Ichiyo","family":"Shibahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiko","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Mayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Mashiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Uenohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Kumabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiji","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"key":"302_CR1","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.1523\/JNEUROSCI.3242-12.2012","volume":"32","author":"DH Gutmann","year":"2012","unstructured":"Gutmann DH, Parada LF, Silva AJ et al (2012) Neurofibromatosis type 1: modeling CNS dysfunction. J Neurosci 32:14087\u201314093","journal-title":"J Neurosci"},{"key":"302_CR2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","volume":"45","author":"Neurofibromatosis","year":"1988","unstructured":"Neurofibromatosis (1988) Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575\u2013578","journal-title":"Arch Neurol"},{"key":"302_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","volume":"151","author":"SA Rasmussen","year":"2000","unstructured":"Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151:33\u201340","journal-title":"Am J Epidemiol"},{"key":"302_CR4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.59.5.759","volume":"59","author":"DH Gutmann","year":"2002","unstructured":"Gutmann DH, Rasmussen SA, Wolkenstein P et al (2002) Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology 59:759\u2013761","journal-title":"Neurology"},{"key":"302_CR5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/NEN.0b013e318165eb75","volume":"67","author":"FJ Rodriguez","year":"2008","unstructured":"Rodriguez FJ, Perry A, Gutmann DH et al (2008) Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 67:240\u2013249","journal-title":"J Neuropathol Exp Neurol"},{"key":"302_CR6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98\u2013110","journal-title":"Cancer Cell"},{"key":"302_CR7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bpa.12295","volume":"26","author":"S Alexandrescu","year":"2016","unstructured":"Alexandrescu S, Korshunov A, Lai SH et al (2016) Epithelioid glioblastomas and anaplastic epithelioid pleomorphic xanthoastrocytomas-same entity or first cousins? Brain pathology 26:215\u2013223","journal-title":"Brain pathology"},{"key":"302_CR8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/PAS.0b013e31827f9c5e","volume":"37","author":"BK Kleinschmidt-DeMasters","year":"2013","unstructured":"Kleinschmidt-DeMasters BK, Aisner DL, Birks DK et al (2013) Epithelioid GBMs show a high percentage of BRAF V600E mutation. Am J Surg Pathol 37:685\u2013698","journal-title":"Am J Surg Pathol"},{"key":"302_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/1793-5482.161166","volume":"10","author":"G Singh","year":"2015","unstructured":"Singh G, Das KK, Sharma P et al (2015) Cerebral gliosarcoma: analysis of 16 patients and review of literature. Asian J Neurosurg 10:195\u2013202","journal-title":"Asian J Neurosurg"},{"key":"302_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-010-0065-6","author":"Y Sonoda","year":"2010","unstructured":"Sonoda Y, Yokosawa M, Saito R et al (2010) O (6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma. Int J Clin Oncol. https:\/\/doi.org\/10.1007\/s10147-010-0065-6","journal-title":"Int J Clin Oncol"},{"key":"302_CR11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10147-011-0323-2","volume":"17","author":"I Shibahara","year":"2012","unstructured":"Shibahara I, Sonoda Y, Kanamori M et al (2012) IDH1\/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas. Int J Clin Oncol 17:551\u2013561","journal-title":"Int J Clin Oncol"},{"key":"302_CR12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/neuonc\/not066","volume":"15","author":"I Shibahara","year":"2013","unstructured":"Shibahara I, Sonoda Y, Saito R et al (2013) The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence. Neuro Oncol 15:1151\u20131159","journal-title":"Neuro Oncol"},{"key":"302_CR13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/carcin\/bgh049","volume":"25","author":"K Fransen","year":"2004","unstructured":"Fransen K, Klintenas M, Osterstrom A et al (2004) Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 25:527\u2013533","journal-title":"Carcinogenesis"},{"key":"302_CR14","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/j.1349-7006.2009.01270.x","volume":"100","author":"Y Sonoda","year":"2009","unstructured":"Sonoda Y, Kumabe T, Nakamura T et al (2009) Analysis of IDH1 and IDH2 mutations in Japanese glioma patients. Cancer Sci 100:1996\u20131998","journal-title":"Cancer Sci"},{"key":"302_CR15","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM et al (2015) Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372:2499\u20132508","journal-title":"N Engl J Med"},{"key":"302_CR16","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1200\/JCO.2009.23.0805","volume":"27","author":"M Weller","year":"2009","unstructured":"Weller M, Felsberg J, Hartmann C et al (2009) Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J Clin Oncol 27:5743\u20135750","journal-title":"J Clin Oncol"},{"key":"302_CR17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1440-1827.2005.01835.x","volume":"55","author":"S Miyata","year":"2005","unstructured":"Miyata S, Sugimoto T, Kodama T et al (2005) Adenoid glioblastoma arising in a patient with neurofibromatosis type-1. Pathol Int 55:348\u2013352","journal-title":"Pathol Int"},{"key":"302_CR18","first-page":"286","volume":"23","author":"H Kroh","year":"2004","unstructured":"Kroh H, Matyja E, Marchel A et al (2004) Heavily lipidized, calcified giant cell glioblastoma in an 8-year-old patient, associated with neurofibromatosis type 1 (NF1): report of a case with long-term survival. Clin Neuropathol 23:286\u2013291","journal-title":"Clin Neuropathol"},{"key":"302_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.14791\/btrt.2014.2.1.36","volume":"2","author":"TS Jeong","year":"2014","unstructured":"Jeong TS, Yee GT (2014) Glioblastoma in a patient with neurofibromatosis type 1: a case report and review of the literature. Brain Tumor Res Treat 2:36\u201338","journal-title":"Brain Tumor Res Treat"},{"key":"302_CR20","first-page":"58","volume":"32","author":"A Taraszewska","year":"2013","unstructured":"Taraszewska A, Bogucki J, Powala A et al (2013) Giant cell glioblastoma with unique bilateral cerebellopontine angle localization considered as extraaxial tumor growth in a patient with neurofibromatosis Type 1. Clin Neuropathol 32:58\u201365","journal-title":"Clin Neuropathol"},{"key":"302_CR21","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2016) WHO classification of tumours of the central nervous system, 4th edn. IARC Press, Lyon"},{"key":"302_CR22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1186\/1479-7364-5-6-623","volume":"5","author":"S Laycock-van Spyk","year":"2011","unstructured":"Laycock-van Spyk S, Thomas N, Cooper DN et al (2011) Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Hum Genom 5:623\u2013690","journal-title":"Hum Genom"},{"key":"302_CR23","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","volume":"68","author":"DT Jones","year":"2008","unstructured":"Jones DT, Kocialkowski S, Liu L et al (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673\u20138677","journal-title":"Cancer Res"},{"key":"302_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10143-011-0362-1","volume":"35","author":"AO Adeleye","year":"2012","unstructured":"Adeleye AO, Okolo CA, Akang EE et al (2012) Cerebral pleomorphic xanthoastrocytoma associated with NF1: an updated review with a rare atypical case from Africa. Neurosurg Rev 35:313\u2013319 (discussion 319)","journal-title":"Neurosurg Rev"},{"key":"302_CR25","first-page":"7570","volume":"8","author":"H Takei","year":"2015","unstructured":"Takei H, Rouah E, Bhattacharjee MB (2015) Cerebellar pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1: a case report and literature review. Int J Clin Exp Pathol 8:7570\u20137574","journal-title":"Int J Clin Exp Pathol"},{"key":"302_CR26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3171\/jns.2005.102.2.0376","volume":"102","author":"S Saikali","year":"2005","unstructured":"Saikali S, Le Strat A, Heckly A et al (2005) Multicentric pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1. Case report and review of the literature. J Neurosurg 102:376\u2013381","journal-title":"J Neurosurg"},{"key":"302_CR27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00234-004-1216-0","volume":"46","author":"MJ Naidich","year":"2004","unstructured":"Naidich MJ, Walker MT, Gottardi-Littell NR et al (2004) Cerebellar pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1. Neuroradiology 46:825\u2013829","journal-title":"Neuroradiology"},{"key":"302_CR28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2006.03.020","volume":"247","author":"S Hariharan","year":"2006","unstructured":"Hariharan S, Donahue JE, Garre C et al (2006) Clinicopathologic and genetic analysis of siblings with NF1 and adult-onset gliomas. J Neurol Sci 247:105\u2013108","journal-title":"J Neurol Sci"},{"key":"302_CR29","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1158\/1078-0432.CCR-13-0551","volume":"19","author":"WC Rutledge","year":"2013","unstructured":"Rutledge WC, Kong J, Gao J et al (2013) Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class. Clin Cancer Res 19:4951\u20134960","journal-title":"Clin Cancer Res"},{"key":"302_CR30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","volume":"15","author":"N Ratner","year":"2015","unstructured":"Ratner N, Miller SJ (2015) A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer 15:290\u2013301","journal-title":"Nat Rev Cancer"},{"key":"302_CR31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1440-1789.2012.01326.x","volume":"33","author":"AD Singh","year":"2013","unstructured":"Singh AD, Iftinca M, Easaw JC (2013) Lipidized glioblastoma: pathological and molecular characteristics. Neuropathology 33:87\u201392","journal-title":"Neuropathology"},{"key":"302_CR32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1440-1789.2010.01141.x","volume":"31","author":"K Gupta","year":"2011","unstructured":"Gupta K, Kalra I, Salunke P et al (2011) Lipidized glioblastoma: a rare differentiation pattern. Neuropathology 31:93\u201397","journal-title":"Neuropathology"},{"key":"302_CR33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10014-015-0231-7","volume":"33","author":"M Kanamori","year":"2016","unstructured":"Kanamori M, Suzuki H, Takei H et al (2016) Malignant transformation of diffuse astrocytoma to glioblastoma associated with newly developed BRAF V600E mutation. Brain Tumor Pathol 33:50\u201356","journal-title":"Brain Tumor Pathol"},{"key":"302_CR34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-013-1141-6","volume":"126","author":"H Arita","year":"2013","unstructured":"Arita H, Narita Y, Fukushima S et al (2013) Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126:267\u2013276","journal-title":"Acta Neuropathol"},{"key":"302_CR35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/neup.12318","volume":"37","author":"N Matsumura","year":"2017","unstructured":"Matsumura N, Nakajima N, Yamazaki T et al (2017) Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma. Neuropathology 37:58\u201363","journal-title":"Neuropathology"},{"key":"302_CR36","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/pbc.22462","volume":"54","author":"AJ Huttner","year":"2010","unstructured":"Huttner AJ, Kieran MW, Yao X et al (2010) Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1. Pediatr Blood Cancer 54:890\u2013896","journal-title":"Pediatr Blood Cancer"},{"key":"302_CR37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/neuonc\/not146","volume":"16","author":"S Dahiya","year":"2014","unstructured":"Dahiya S, Emnett RJ, Haydon DH et al (2014) BRAF-V600E mutation in pediatric and adult glioblastoma. Neuro Oncol 16:318\u2013319","journal-title":"Neuro Oncol"},{"key":"302_CR38","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.humpath.2015.05.014","volume":"46","author":"MA Vizcaino","year":"2015","unstructured":"Vizcaino MA, Shah S, Eberhart CG et al (2015) Clinicopathologic implications of NF1 gene alterations in diffuse gliomas. Hum Pathol 46:1323\u20131330","journal-title":"Hum Pathol"},{"key":"302_CR39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40246-017-0109-3","volume":"11","author":"C Philpott","year":"2017","unstructured":"Philpott C, Tovell H, Frayling IM et al (2017) The NF1 somatic mutational landscape in sporadic human cancers. Hum Genom 11:13","journal-title":"Hum Genom"},{"key":"302_CR40","first-page":"1235","volume":"29","author":"B Bikowska-Opalach","year":"2014","unstructured":"Bikowska-Opalach B, Szlufik S, Grajkowska W et al (2014) Pilocytic astrocytoma: a review of genetic and molecular factors, diagnostic and prognostic markers. Histol Histopathol 29:1235\u20131248","journal-title":"Histol Histopathol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-017-0302-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-017-0302-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-017-0302-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T16:38:06Z","timestamp":1719592686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-017-0302-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1007\/s10014-017-0302-z","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,14]]}}}